LIGAND PHARMACEUTICALS INC - NOTE 0.750% 8/1

Q1 2017 13F Holders as of 3/31/2017

Type / Class
Debt / NOTE 0.750% 8/1
Number of holders
26
Total Principal
244M
Shares change
+2.78M
Total reported value, excl. options
$364M
Value change
+$6.25M
Put/Call ratio
0
Number of buys
10
Number of sells
-9
Price
$1.49
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.